Erratum: Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum

Medicine (Baltimore). 2017 Jul 21;96(29):e7644. doi: 10.1097/MD.0000000000007644. eCollection 2017 Jul.

Abstract

[This corrects the article DOI: 10.1097/MD.0000000000006985.].

Publication types

  • Published Erratum